UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041965
Receipt number R000047903
Scientific Title Retrospective study to identify prognostic factor for the patients with acute liver injury
Date of disclosure of the study information 2020/10/01
Last modified on 2020/10/01 16:50:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective study to identify prognostic factor for the patients with acute liver injury

Acronym

Prognostic factor for the patients with acute liver injury

Scientific Title

Retrospective study to identify prognostic factor for the patients with acute liver injury

Scientific Title:Acronym

Prognostic factor for the patients with acute liver injury

Region

Japan


Condition

Condition

Acute liver injury

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the prognostic factor of the patients with acute liver injury

Basic objectives2

Others

Basic objectives -Others

Prognosis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Deceased

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Acute liver injury

Key exclusion criteria

The subjects who do not wish to participate or are considered as ineligible by the attending physician.

Target sample size

312


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Takikawa

Organization

Iwate medical university

Division name

Department of internal medicine, Division of Hepatology

Zip code

028-3694

Address

Idaidori 1-1-1, Yahaba cho, Iwate

TEL

019-651-5111

Email

ytakikaw@iwate-med.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name Kakisaka
Last name Kakisaka

Organization

Iwate medical university

Division name

Department of internal medicine, Division of Hepatology

Zip code

028-3028

Address

Idaidori 1-1-1, Yahaba cho, Iwate

TEL

0196515111

Homepage URL


Email

keikaki@iwate-med.ac.jp


Sponsor or person

Institute

Iwate medical university

Institute

Department

Personal name



Funding Source

Organization

Iwate medical university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Iwate medical university, school of medicine

Address

Idaidori 1-1-1, Yahaba cho, Iwate

Tel

019-651-5111

Email

kenkyu-rinri@j.iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

312

Results

Among the 312 patients with acute liver injury, the patients who progressed to acute liver failure (ALF) revealed poor prognosis. In these patients, autoimmune hepatitis or oral infected viral hepatitis showed good prognosis. In contrast, drug-induced liver injury or HBV carrier had a poor prognosis.

Results date posted

2020 Year 10 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 11 Month 12 Day

Date of IRB

2019 Year 11 Month 12 Day

Anticipated trial start date

2019 Year 11 Month 12 Day

Last follow-up date

2019 Year 11 Month 12 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Since this is a retrospective study, date of protocol fixation and last follow-up date are the same date.


Management information

Registered date

2020 Year 10 Month 01 Day

Last modified on

2020 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047903


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name